Other
Coadministration of gemfibrozil results in increased repaglinide plasma concentration 8-fold increase ; may lead to severe hypoglycemia. |
Take care not to let your blood sugar get too low. |
Coadministration of gemfibrozil results in increased repaglinide plasma concentration 8-fold increase ; may lead to severe hypoglycemia. Patients at risk of severe hypoglycemia: Elderly, debilitated, or malnourished; adrenal or pituitary insufficiency. |
Possible side effects 5. Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. |
Repaglinide 1mg Tablets 2. Qualitative and quantitative composition Each tablet contains 1 mg of repaglinide. |
Repaglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus NIDDM. The therapeutic efficacy of Repaglinide can be increased when used in combination with Acebutolol. |
Before taking acarbose, tell your doctor if you have liver disease, or any type of stomach or intestinal disorder. |
An inhibitor of alpha glucosidase that retards the digestion and absorption of carbohydrates in the small intestine and hence reduces the increase in blood-glucose concentrations after a carbohydrate load. It is given orally to non-insulin dependent diabetes mellitus patients where diet modification or oral hypoglycemic agents do not control their condition. |
Your medication may look different. If you have questions, ask your pharmacist. |
Acarbose INN is an anti-diabetic drug used to treat diabetes mellitus type 2 and, in some countries, prediabetes. |









